Literature DB >> 29201946

Cell-free Fluorescent Intra-Golgi Retrograde Vesicle Trafficking Assay.

Nathanael P Cottam1, Daniel Ungar1.   

Abstract

Intra-Golgi retrograde vesicle transport is used to traffic and sort resident Golgi enzymes to their appropriate cisternal locations. An assay was established to investigate the molecular details of vesicle targeting in a cell-free system. Stable cell lines were generated in which the trans-Golgi enzyme galactosyltransferase (GalT) was tagged with either CFP or YFP. Given that GalT is recycled to the cisterna where it is located at steady state, GalT-containing vesicles target GalT-containing cisternal membranes. Golgi membranes were therefore isolated from GalT-CFP expressing cells, while vesicles were prepared from GalT-YFP expressing ones. Incubating CFP-labelled Golgi with YFP-labelled vesicles in the presence of cytosol and an energy regeneration mixture at 37 °C produced a significant increase in CFP-YFP co-localization upon fluorescent imaging of the mixture compared to incubation on ice. The assay was validated to require energy, proteins and physiologically important trafficking components such as Rab GTPases and the conserved oligomeric Golgi tethering complex. This assay is useful for the investigation of both physiological and pathological changes that affect the Golgi trafficking machinery, in particular, vesicle tethering.

Entities:  

Keywords:  Conserved oligomeric Golgi complex; Fluorescent imaging; Galactosyltransferase; Golgi apparatus; Vesicle tethering; Vesicle trafficking

Year:  2017        PMID: 29201946      PMCID: PMC5706631          DOI: 10.21769/BioProtoc.2616

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  10 in total

Review 1.  SNARE protein structure and function.

Authors:  Daniel Ungar; Frederick M Hughson
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

Review 2.  Retrograde vesicle transport in the Golgi.

Authors:  Nathanael P Cottam; Daniel Ungar
Journal:  Protoplasma       Date:  2011-12-12       Impact factor: 3.356

3.  Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation.

Authors:  Jürgen Lübbehusen; Christian Thiel; Nina Rind; Daniel Ungar; Berthil H C M T Prinsen; Tom J de Koning; Peter M van Hasselt; Christian Körner
Journal:  Hum Mol Genet       Date:  2010-07-06       Impact factor: 6.150

4.  Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder.

Authors:  Xiaohua Wu; Richard A Steet; Ognian Bohorov; Jaap Bakker; John Newell; Monty Krieger; Leo Spaapen; Stuart Kornfeld; Hudson H Freeze
Journal:  Nat Med       Date:  2004-04-25       Impact factor: 53.440

5.  Rab GDI: a solubilizing and recycling factor for rab9 protein.

Authors:  T Soldati; M A Riederer; S R Pfeffer
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

6.  Reconstitution of the transport of protein between successive compartments of the Golgi measured by the coupled incorporation of N-acetylglucosamine.

Authors:  W E Balch; W G Dunphy; W A Braell; J E Rothman
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

7.  Isolation of functional Golgi-derived vesicles with a possible role in retrograde transport.

Authors:  H D Love; C C Lin; C S Short; J Ostermann
Journal:  J Cell Biol       Date:  1998-02-09       Impact factor: 10.539

Review 8.  Bridging the Gap between Glycosylation and Vesicle Traffic.

Authors:  Peter Fisher; Daniel Ungar
Journal:  Front Cell Dev Biol       Date:  2016-03-08

9.  Three types of low density lipoprotein receptor-deficient mutant have pleiotropic defects in the synthesis of N-linked, O-linked, and lipid-linked carbohydrate chains.

Authors:  D M Kingsley; K F Kozarsky; M Segal; M Krieger
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

10.  Dissecting functions of the conserved oligomeric Golgi tethering complex using a cell-free assay.

Authors:  Nathanael P Cottam; Katherine M Wilson; Bobby G Ng; Christian Körner; Hudson H Freeze; Daniel Ungar
Journal:  Traffic       Date:  2013-10-31       Impact factor: 6.215

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.